Procept BioRobotics Target Price

See Procept BioRobotics's analyst price targets ($24) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.83

Average Target Price

$24.27

16.5% upside

11 analysts in the last 4 months

High: $35 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-05	Truist Financial	$21	0.8% upside
2026-08-05	Evercore ISI	$23	10.4% upside
2026-08-05	Robert W. Baird	$20	4% downside
2026-08-05	Piper Sandler	$25	20% upside
2026-08-05	Wells FargoNathan Treybeck	$19	8.8% downside
2026-08-05	JefferiesMichael Sarcone	$20	4% downside
2026-07-28	UBS	$20	4% downside
2026-07-02	Truist Financial	$25	20% upside
2026-06-24	Evercore ISIVijay Kumar	$30	44% upside
2026-06-11	Leerink Partners	$29	39.2% upside
2026-04-30	Piper SandlerMatt O'Brien	$35	68% upside
2026-02-27	Truist FinancialRichard Newitter	$30	44% upside
2026-02-26	Wells FargoNathan Treybeck	$34	63.2% upside
2025-12-18	Truist FinancialRichard Newitter	$47	125.6% upside
2025-12-12	UBSDanielle Antalffy	$62	197.6% upside
2025-12-02	Morgan StanleyPatrick Wood	$51	144.8% upside
2025-11-05	Piper SandlerMatt O'Brien	$50	140% upside
2025-11-05	Leerink PartnersMike Kratky	$55	164% upside
2025-11-05	Wells Fargo	$51	144.8% upside
2025-10-15	Truist Financial	$50	140% upside
2025-09-02	OppenheimerSuraj Kalia	$60	188% upside
2024-12-02	Morgan StanleyPatrick Wood	$105	404.1% upside
2024-10-29	Truist FinancialRichard Newitter	$105	404.1% upside
2024-09-03	Truist FinancialRichard Newitter	$95	356.1% upside
2024-07-16	Truist FinancialRichard Newitter	$79	279.3% upside
2024-05-06	Piper SandlerMatt O'Brien	$75	260.1% upside
2024-05-02	Truist FinancialRichard Newitter	$72	245.7% upside
2022-09-02	Wells FargoNathan Treybeck	$49	135.2% upside

Procept BioRobotics (PRCT) FAQ

As of the most recent data, PRCT shows a target price of $24. Scroll down for historical charts and peer comparison views.

If Procept BioRobotics moved to the average analyst target of $24, shares would be roughly 16.5% higher than $20.83. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Procept BioRobotics's earnings trajectory.

Besides this target price page, Stockcircle has Procept BioRobotics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $24) with ownership activity and broader fundamentals.

Procept BioRobotics's target price is $24; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.